Viewing nowGenewon Cilostazol Extended Release Capsule 100 mg (Cilostazol)
Cilostazol 100mg
Hard capsule · Prescription medication
Genewon Science Co., Ltd.

MFDS item code 201907299 · Approved 2019.10.17 · Insurance code 671706160
Improvement of chronic arterial occlusion (ulcers, pain) and prevention of recurrence of cerebral infarction.
This medication is used to improve ischemic symptoms such as ulcers, pain, and coldness caused by chronic arterial occlusion, Buerger's disease, atherosclerosis, and diabetic peripheral vascular disease. It also helps to prevent recurrence after a cerebral infarction, particularly excluding cardiogenic cerebral embolism. By improving blood circulation, it alleviates ischemic symptoms and is effective in preventing the recurrence of cerebral infarction. Therefore, it can be used to enhance vascular health and relieve symptoms.
Typically, for adults, 200 mg is taken orally once a day. This drug should be taken on an empty stomach, avoiding meals.
This medication may increase heart rate, which can pose a risk for symptoms of angina, so symptoms such as chest pain should be closely monitored. Patients at risk of bleeding or those who have had recent bleeding, patients with congestive heart failure, patients with a history of allergic reactions to this drug or its components, pregnant or potentially pregnant women and nursing mothers should not take this medication. Patients taking anticoagulants, antiplatelet agents, thrombolytics, women during menstruation, patients with coronary artery stenosis, severely impaired kidney or liver function, diabetic patients, patients with consistently high blood pressure, and patients with certain heart conditions should use this medication with caution. Side effects such as headaches, diarrhea, palpitations, joint swelling, and chest discomfort may occur. In severe cases, symptoms like bleeding, blood cell reductions, interstitial pneumonia, heart failure, myocardial infarction may occur, and if abnormal symptoms appear, immediate consultation with a doctor is recommended. This medication is administered after symptoms stabilize in cerebral infarction patients, and caution should be exercised regarding blood pressure control and signs of bleeding when taken with other blood coagulation-related medications due to increased risk of bleeding. Dizziness may occur during use, so caution is advised when driving or operating machinery. Taking this medication with food may increase blood concentration, raising the risk of side effects; therefore, it is recommended to take it on an empty stomach and maintain a minimum interval of 3 hours between meals and medication. As this drug is metabolized in the liver, it may interact with certain medications, and when taken with drugs that inhibit liver metabolic enzymes, blood concentration may increase, necessitating careful dosage adjustment and monitoring. Pregnant or nursing mothers should not take this drug, as negative effects on the fetus have been reported in animal studies. Safety in children and infants has not been adequately confirmed, so caution is needed for use. Elderly patients may have reduced physical functions, necessitating careful dosage adjustments. In case of overdose, symptoms such as headache, diarrhea, low blood pressure, and heart rhythm abnormalities may occur, requiring immediate medical attention.
Hives, severe swelling (edema), chest pain, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in mouth/eye mucous membranes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of skin or eyes), extreme fatigue, sudden and severe headaches, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, extremely reduced urine output.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container, away from air and moisture, and maintained at room temperature between 1 and 30 degrees Celsius. It is crucial to avoid direct sunlight and high temperatures and to store it safely out of reach of children.
A hard capsule with a white or pale yellow granular content, with both ends in white.
30 capsules/bottle, 500 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCilostazol 100mg
Hard capsule · Prescription medication
Genewon Science Co., Ltd.

Cilostazol 50mg
Tablet · Prescription medication
Otsuka Pharmaceutical Co., Ltd.

Cilostazol 100mg
Tablet · Prescription medication
Korea Otsuka Pharmaceutical Co., Ltd.

Cilostazol 50mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Cilostazol 50mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Cilostazol 100mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Cilostazol 50mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Cilostazol
Prescription medication
Daehan New Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.